Codexis Inc (CDXS) (Q3 2026) Earnings Call Highlights: Revenue Surges 124% as ECO Synthesis ...
Codexis Inc (CDXS) posted $19.3 million in Q3 2026 revenue, its fourth straight on-target quarter, while advancing enzymatic oligonucleotide manufacturing and extending its cash runway through 2028. Related Stocks: CDXS ,